Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Rose 49.6% in First Quarter of 2022

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 5.6 million yuan in the first quarter of 2022, up 49.6% year-on-year.

Meanwhile, the company posted 357.6 million yuan in revenue, down 6.6% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 49.4%.